See our new privacy terms at https://privacy.abbvie/.
Register now to begin training or log in to your account
*The safety and efficacy of these products for combined use have not been studied.
SKINVIVE™ by JUVÉDERM® injectable gel is indicated for intradermal injection to improve skin smoothness of the cheeks in adults over the age of 21.
SKINVIVE™ by JUVÉDERM® injectable gel is indicated for intradermal injection to improve skin smoothness of the cheeks in adults over the age of 21.
This product should not be used in patients who have severe allergies, marked by a history of anaphylaxis or history or presence of multiple severe allergies, and should not be used in patients with a history of allergies to Gram-positive bacterial proteins or lidocaine contained in this product.
In clinical studies, injection site responses (ISRs) observed in >5% of treated subjects included redness, lumps/bumps, swelling, bruising, pain, tenderness, firmness, discoloration, and itching. Most ISRs were mild. Adverse events reported through postmarketing surveillance outside of the United States included inflammatory reaction, inflammatory nodule, unsatisfactory result, loss/lack of correction, allergic reaction, anxiety, vascular occlusion, infection, dry skin, increase/decrease in sensation, and abscess.
To report an adverse reaction with SKINVIVE™ by JUVÉDERM®, please call the Allergan® Product Support Department at 1-877-345-5372. Please see Directions for Use or visit SKINVIVEDFU.com for more information.
SKINVIVE™ by JUVÉDERM® is available only by a licensed physician or properly licensed practitioner.
JUVÉDERM® VOLBELLA® XC injectable gel is indicated for injection into the lips for lip augmentation and correction of perioral rhytids, and for the improvement of infraorbital hollowing in adults over the age of 21.
This product should not be used in patients who have severe allergies, marked by a history of anaphylaxis or history or presence of multiple severe allergies, and should not be used in patients with a history of allergies to Gram-positive bacterial proteins or lidocaine contained in this product.
The most commonly reported side effects for JUVÉDERM® VOLBELLA® XC injectable gel were redness, swelling, pain, tenderness, firmness, lumps/bumps, bruising, discoloration, itching, and dryness. Most were predominantly mild or moderate in severity, with duration of 30 days or less.
To report an adverse reaction with JUVÉDERM® VOLBELLA® XC, please call the Allergan® Product Support Department at 1-877-345-5372. Please visit JuvedermDFU.com for more information.
JUVÉDERM® VOLBELLA® XC injectable gel is available only by a licensed physician or properly licensed practitioner.